Precision BioSciences Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) Transcript
Good afternoon. Thank you all for joining the 5th Annual Guggenheim Genomic Medicines and Rare Disease Conference. I am Robert. I'm one of the analysts representing the Guggenheim therapeutics team. Today, we are thankful to host Precision BioSciences' Chief Executive, Michael Amoroso.
Thank you.
And Co-founder and Chief Science Officer, Derek Jantz. Thank you both for joining us.
And, Michael, I'd like to hand it over to you for an introduction to the company.
Sure. Well, Robert and to the Guggenheim team, thank you for having us. Precision BioSciences, we are a group out of Durham, North Carolina. We are premier gene-editing group, genomic editing based on the platform of -- that this man, to my left, helped co-create known as the ARCUS proprietary platform.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |